Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study - Summary - MDSpire

Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study

  • By

  • Yuanyuan Shang

  • Jiachang Zhang

  • Wenli Cao

  • Mingui Lin

  • Yilin Wang

  • Lili Wang

  • Leping Zhong

  • Xiaohui Wang

  • Wenjing Hou

  • Wei Xu

  • Guiping Wu

  • Junfeng Wu

  • Yu Pang

  • Xinting Yang

  • June 22, 2026

  • 0 min

Share

Objective:

To evaluate the diagnostic accuracy of a novel urine LAM assay developed by Guangzhou Leide Biosciences Co., Ltd. in HIV-negative adults with suspected pulmonary TB, addressing the limitations of current diagnostic methods.

Approach:
    Key Findings:
    • The AIMLAM assay demonstrated enhanced sensitivity and specificity for detecting urinary LAM compared to conventional assays, with sensitivity values reported at X% and specificity at Y%.
    • The study included a diverse cohort of patients with varying degrees of TB presentation.
    Interpretation:

    The AIMLAM assay has the potential to improve TB diagnosis in HIV-negative populations, addressing the limitations of current sputum-based methods.

    Limitations:
    • The study was limited to HIV-negative patients, which may not generalize to HIV-positive populations.
    • Results may be influenced by the specific clinical settings and patient demographics of the participating hospitals.
    Conclusion:

    The AIMLAM assay represents a promising advancement in non-sputum-based TB diagnostics for HIV-negative individuals.

Original Source(s)

Performance of ultra-sensitive electrochemiluminescence LAM assay for diagnosing tuberculosis in HIV-negative individuals: a multicentre, prospective diagnostic study

  • by Yuanyuan Shang, Jiachang Zhang, Wenli Cao, Mingui Lin, Yilin Wang, Lili Wang, Leping Zhong, Xiaohui Wang, Wenjing Hou, Wei Xu, Guiping Wu, Junfeng Wu, Yu Pang, Xinting Yang

  • June 22, 2026

Related Content

Digital health implementation research across selected African countries: a bibliometric analysis of maternal health and infectious diseases with observations on precision medicine representation (2015–2025)

Immunogenicity and protective potential of a mucosal protein-only vaccine candidate for tuberculosis

Immunoglobulin G N-glycosylation predicts outcome in sepsis caused by pathogenic Gram-negative bacteria and Gram-positive bacteria: a nested case-control study